Barbara Slusher
Consultant / Advisor chez JOHNSON & JOHNSON
Profil
Barbara S.
Slusher is the founder of Avalo Therapeutics, Inc. (2011).
She is also the founder of Dracen Pharmaceuticals, Inc., Adarga Ltd.
Dr. Slusher's current jobs include serving as a Board of Director at Ashvattha Therapeutics Inc, and as a member of the Scientific Advisory Board at Johnson & Johnson, Eisai, Inc., Bluefield Innovations LLC, and as a Venture Partner at Catalio Capital Management LP.
Dr. Slusher's former job was as SVP-Research, Toxicology & Animal Sciences at Guilford Pharmaceuticals, Inc. Dr. Slusher's education includes an undergraduate degree from Dickinson College, and graduate and doctorate degrees from The Johns Hopkins University.
Postes actifs de Barbara Slusher
| Sociétés | Poste | Début |
|---|---|---|
| JOHNSON & JOHNSON | Consultant / Advisor | - |
Ashvattha Therapeutics Inc
 Ashvattha Therapeutics Inc Pharmaceuticals: MajorHealth Technology Ashvattha Therapeutics LLC provides healthcare services. The firm develops pharmaceutical products. The company is headquartered in Redwood City, CA. | Directeur/Membre du Conseil | - |
Catalio Capital Management LP
 Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Private Equity Investor | - |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Consultant / Advisor | - |
Bluefield Innovations LLC
 Bluefield Innovations LLC Financial ConglomeratesFinance Bluefield Innovations LLC engages in the commercialization and development of early stage therapeutic research. It includes basic research, proof of concept, target selection and investigational new drug (IND) enabling studies designed to qualify a candidate to enter into human clinical trials. The company was founded in November 2017 and is headquartered in New York, NY. | Consultant / Advisor | - |
Anciens postes connus de Barbara Slusher
| Sociétés | Poste | Fin |
|---|---|---|
Guilford Pharmaceuticals, Inc.
 Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Directeur Technique/Scientifique/R&D | 03/10/2005 |
Adarga Ltd.
 Adarga Ltd. Packaged SoftwareTechnology Services Adarga Ltd. develops machine learning techniques to read and understand complex data. Its products include adarga_engine and adarga_bench. The company was founded by Robert Bassett Cross in 2016 and is headquartered in London, the United Kingdom. | Fondateur | - |
Dracen Pharmaceuticals, Inc.
 Dracen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dracen Pharmaceuticals, Inc. develops immuno-metabolism drugs. The company was founded by Barbara Slusher, Jonathan D. Powell, Pavel Majer, and Rana Rais and is headquartered in New York, NY. | Fondateur | - |
| AVALO THERAPEUTICS, INC. | Fondateur | - |
Formation de Barbara Slusher
| Dickinson College | Undergraduate Degree |
| The Johns Hopkins University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| AVALO THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Guilford Pharmaceuticals, Inc.
Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
Ashvattha Therapeutics Inc
Ashvattha Therapeutics Inc Pharmaceuticals: MajorHealth Technology Ashvattha Therapeutics LLC provides healthcare services. The firm develops pharmaceutical products. The company is headquartered in Redwood City, CA. | Health Technology |
Bluefield Innovations LLC
Bluefield Innovations LLC Financial ConglomeratesFinance Bluefield Innovations LLC engages in the commercialization and development of early stage therapeutic research. It includes basic research, proof of concept, target selection and investigational new drug (IND) enabling studies designed to qualify a candidate to enter into human clinical trials. The company was founded in November 2017 and is headquartered in New York, NY. | Finance |
Dracen Pharmaceuticals, Inc.
Dracen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dracen Pharmaceuticals, Inc. develops immuno-metabolism drugs. The company was founded by Barbara Slusher, Jonathan D. Powell, Pavel Majer, and Rana Rais and is headquartered in New York, NY. | Health Technology |
Adarga Ltd.
Adarga Ltd. Packaged SoftwareTechnology Services Adarga Ltd. develops machine learning techniques to read and understand complex data. Its products include adarga_engine and adarga_bench. The company was founded by Robert Bassett Cross in 2016 and is headquartered in London, the United Kingdom. | Technology Services |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Finance |
